Regenerative Medical Technology Group Inc.
RMTG
$0.0486
$0.020975.45%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 52.49% | 119.51% | 3.92% | 8.71% | 75.90% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 52.49% | 119.51% | 3.92% | 8.71% | 75.90% |
| Cost of Revenue | 21.73% | 147.81% | -0.56% | -12.83% | 91.15% |
| Gross Profit | 65.91% | 107.60% | 6.00% | 21.18% | 69.99% |
| SG&A Expenses | 49.67% | 1.63% | 4.02% | 30.71% | 19.85% |
| Depreciation & Amortization | -10.03% | 43.35% | 35.34% | 89.26% | 148.61% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 33.87% | 24.57% | 4.74% | 20.96% | 44.91% |
| Operating Income | 131.73% | 55.48% | -13.61% | -153.63% | 43.52% |
| Income Before Tax | 84.85% | -2.29% | -17.41% | 75.87% | -335.84% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 84.85% | -2.29% | -17.41% | 75.87% | -335.84% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 84.85% | -2.29% | -17.41% | 74.20% | -335.67% |
| EBIT | 131.73% | 55.48% | -13.61% | -153.63% | 43.52% |
| EBITDA | 332.05% | 70.92% | 65.36% | -2,661.54% | 129.04% |
| EPS Basic | 84.96% | -1.90% | -16.99% | 74.44% | -321.40% |
| Normalized Basic EPS | 49.20% | -1.86% | -16.79% | -64.68% | -24.64% |
| EPS Diluted | 84.96% | -1.90% | -16.99% | 73.78% | -321.40% |
| Normalized Diluted EPS | 49.20% | -1.86% | -16.79% | -64.68% | -24.64% |
| Average Basic Shares Outstanding | 0.76% | 0.40% | 0.40% | 1.13% | 3.42% |
| Average Diluted Shares Outstanding | 0.76% | 0.40% | 0.40% | 1.13% | 3.42% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
